Influence of combinations of enhancers on skin permeation of meloxicam

Drug Delivery System

Volumn 21, Issue 5, 2006, Pages 537-544

  Sawada, Hidenori ^a   Kawakami, Junji ^a   Kawamura, Naohisa ^a   Yamauchi, Hitoshi ^a   Takayama, Satoshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

combination; enhancer; mechanisms of action; meloxicam; pacth

Indexed keywords

EID: 58849132319     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.21.537     Document Type: Article

References (26)

1. Machlis BK, Klostermeyer BS : The cyclooxygenase-2 inhibitors : Safety and effectiveness. The Annals of Pharmacotherapy 33 : 979-988, 1999.
2. Okuda T : COX2 inhibitors. Medicine and Drug Journal 34 : 88-93, 1998.
3. Imai F : COX2 inhibitors. Medicine and Drug Journal 35 : 136-140, 1999.
4. Hosaka S : COX2 inhibitors. Medicine and Drug Journal 36 : 95-99, 2000.
5. Sano O : COX2 inhibitors. Medicine and Drug Journal 36 : 115-124, 2000.
6. Kinoshita T, Akemi H, Ohtsuka S : Preparation design and pharmaceutics basic knowledge of percutaneous absorption pharmaceuticals. Shinryo to Shinyaku (Japanese) 30 : 166-175, 1993.
7. Schaefer H et al. : Relationship between the structure of compounds and their diffusion across membranes. Skin Barrier. S Karger AG, Basel, 1996, 87-117.
8. Barry BW : Penetration enhancer classification. Percutaneous Penetration Enhancers. Second Edition. CRC Press, The US, 2006, 3-15.
9. Morimoto Y, Sugibayashi K, Kobayashi D, Shoji H, Yamazaki J et al. : A new enhancer-coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int J Pharm 91 : 9-14, 1993.
10. Aungst BJ, Blake JA, Hussain MA : Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm Res 7 : 712-718, 1990.
11. Sato K, Sugibayashi K, Morimoto Y : Effect and mode of action of aliphatic esters on the in vitro skin permeation of nicorandil. Int J Pharm 43 : 31-40, 1988.
12. Wotton PK, Mollgaard B, Hadgraft I, Hoelgaard A : Vehicle effect on topical drug delivery. 3. Effect of Azone on the cutaneous permeation of metronidazole and propylene glycol. Int J Pharm 24 : 19-26, 1985.
13. Ghanem AH, Mahmoud H, Higuchi WI, Rohr UD, Borsadia S et al. : The effect of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. A new quantitative approach. J Control Release 6 : 75-83, 1987.
14. Sheth NV, Freeman DJ, Higuchi WI, Spruance SL : The influence of Azone, propylene glycol and polyethylene glycol on in vitro skin penetration of trifluorothymidine. Int J Pharm 28 : 201-209, 1986.
15. Higuchi T : Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 11 : 85-97, 1960.
16. Barry BW : Lipid-Protein-Partitioning theory of skin penetration enhancement. J Control Release 15 : 237-248, 1991.
17. Williams AC, Barry BW : The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm 74 : 157-168, 1991.
18. Williams AC, Barry BW : Terpenes and the Lipid-Protein-Partitioning theory of skin permeation enhancement. Pharm Res 8 : 17-24, 1991.
19. Hashida M, Yamashita F : Terpenes as penetration enhancers. Percutaneous Penetration Enhancers. CRC Press, The US, 1995, 309-321.
20. Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML : Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res 8 : 350-354, 1991.
21. Kim CK, Kim JJ, Chi SC, Shim CK : Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm 99 : 109-118, 1993.
22. Takahashi K, Sakano H, Yoshida M, Numata N, Mizuno N : Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release 73 : 351-358, 2001.
23. Rana V, Rai P, Tiwary AK, Gupta S : Enhanced in vitro percutaneous permeation of diclofenac sodium with primary amine and pyrrolidone ion-pairs. Indian Drugs 36 : 21-28, 1999.
24. Dugard PH, Scottv RC : A method of predicting percutaneous absorption rates from vehicle to vehicle : an experimental assessment. Int J Pharm 28 : 219-227, 1986.
25. Morimoto Y, Hatanaka T, Oguchi M, Sugibayashi K, Kobayashi M et al. : A screening method for percutaneous absorption enhancers appropriate for adhesive matrix devices. Pharma Science 2 : 253-258, 1992.
26. K-Mugford P, et al. : In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. AJVR 61 : 802-810, 2000.